Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature.
about
International Consensus Document (ICON): Common Variable Immunodeficiency DisordersUpdate in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsGranulomatous disease in common variable immunodeficiency.Common variable immunodeficiency: etiological and treatment issues.How I treat common variable immune deficiency.Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.Bilateral Idiopathic Solitary Granuloma of the Uveal Tract: Diagnosis and TreatmentInflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.An unusual case of granulomatous lung disease. A clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery.Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.Modern management of primary B-cell immunodeficiencies.A review on guidelines for management and treatment of common variable immunodeficiency.Lung Disease in Primary Antibody Deficiencies.The Lung in Dysregulated States of Humoral Immunity.Common Variable Immunodeficiency and Liver Involvement.Necrotizing and sarcoidal granulomas in the skin and synovial membrane, associated with common variable immunodeficiency.Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency.An update on treatment strategies for common variable immunodeficiency.Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.
P2860
Q26777304-BFDEABF7-919C-4507-93FF-4B4B464A377EQ28240370-D6769AEA-F9C0-44F2-8178-4A595A735049Q33386034-C6A5BD72-A94A-4AB3-B42F-8E8A59F9AA0BQ33621805-865B7225-0F6C-4457-B501-C4838D5BB224Q33997226-535EB4D2-5888-4EA6-ACCE-3FF1FD6F9E79Q34296519-C299C3DF-4934-4288-9EE5-862395F271C1Q34300297-1689D463-4CFC-45BA-BFF1-66858E0FE10BQ36459593-2D22A86F-FD0E-4484-B5CC-43CD82206622Q36777192-F09C22FA-B37B-4F7C-A357-3F33A3591B0FQ36796493-9E402BC4-36E0-47F4-9354-87374557CEDBQ37364113-2BC34987-F21E-4ADD-9B57-CD07034BC4A9Q37962045-A10B7BBC-FA61-46DA-81B3-F31EEC37CAB8Q38111423-4FA95CFC-6315-49DF-9DE2-651ABA8504A0Q39005508-903F0BEC-370B-4BFD-B7C3-53F80034193AQ40045962-2FA1D13F-64ED-403E-9520-387546E0B8A1Q40102527-8CF52D68-3EE9-48A0-A6ED-84B3E7387DD6Q41564385-9DCA2AE6-CC5C-4577-AA60-9192A1BC529DQ41996711-E4BECA31-FFA3-4990-89AF-50ECE745145DQ43793814-98E58E0E-A0CD-43A8-B087-A747D6DD0738Q44024797-2ECB7AE9-CAB8-4B13-8E44-A9C5C656759AQ51515479-DF92FF23-1DBA-41CE-B9A7-D861AA69FCF0
P2860
Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Infliximab treatment for sever ...... and review of the literature.
@ast
Infliximab treatment for sever ...... and review of the literature.
@en
type
label
Infliximab treatment for sever ...... and review of the literature.
@ast
Infliximab treatment for sever ...... and review of the literature.
@en
prefLabel
Infliximab treatment for sever ...... and review of the literature.
@ast
Infliximab treatment for sever ...... and review of the literature.
@en
P2093
P1476
Infliximab treatment for sever ...... and review of the literature.
@en
P2093
Akaluck Thatayatikom
Andrew J White
Sthorn Thatayatikom
P304
P356
10.1016/S1081-1206(10)61228-8
P577
2005-09-01T00:00:00Z